US equities
|
SPCX
$174.98
▲+2.27%
NVDA
$242.22
▲+1.39%
MU
$1,068.87
▲+0.46%
MRVL
$290.29
▲+7.02%
AMD
$652.18
▲+3.23%
SNDK
$1,678.14
▼-1.53%
AVGO
$377.03
▲+4.01%
TSLA
$380.75
▲+0.53%
SPCX
$174.98
▲+2.27%
NVDA
$242.22
▲+1.39%
MU
$1,068.87
▲+0.46%
MRVL
$290.29
▲+7.02%
AMD
$652.18
▲+3.23%
SNDK
$1,678.14
▼-1.53%
AVGO
$377.03
▲+4.01%
TSLA
$380.75
▲+0.53%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Summit Therapeutics Inc. - Common Stock
(NQ:
SMMT
)
16.62
-0.64 (-3.73%)
Delayed Quote
Updated: 10:56 AM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Summit Therapeutics Inc. - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 31, 2024
Via
Benzinga
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study
↗
May 31, 2024
Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 31, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
May 31, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
May 31, 2024
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers on Friday morning!
Via
InvestorPlace
Marvell Technology Posts Weak Q1 Results, Joins MongoDB, Dell Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
May 31, 2024
Via
Benzinga
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
May 30, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 28, 2024
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 28, 2024
Via
Benzinga
Why Summit Therapeutics Stock Is Sinking Today
↗
May 28, 2024
Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 27, 2024
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 24, 2024
Via
Benzinga
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
↗
May 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 24, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
May 24, 2024
We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news!
Via
InvestorPlace
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
May 24, 2024
Via
Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
↗
May 07, 2024
Via
Benzinga
SMMT Stock Earnings: Summit Therapeutics Reported Results for Q1 2024
↗
May 01, 2024
Summit Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
May 01, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
April 24, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
April 11, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
April 10, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Why Summit Therapeutics Stock Crushed the Market This Week
↗
March 29, 2024
The company was a standout in the biotech field, rising by nearly 23% over the period.
Via
The Motley Fool
Akeso Marks Profit Milestone With Swift Rights Issue
↗
March 28, 2024
Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the...
Via
Benzinga
Analysts Eye Summit Therapeutics' Ivonescimab As Potential Challenger To Merck's Keytruda in Lung Cancer Treatment
↗
March 26, 2024
Stifel covers Summit Therapeutics, highlighting ivonescimab's promise in phase 3 lung cancer trials, potential market expansion worth billions, and a buy rating with $8 target. Updates from Akeso in...
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 28, 2024
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...
Via
Benzinga
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
↗
March 26, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Via
Benzinga
Topics
Stocks
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 18, 2024
Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
